Sfoglia per Autore
Preliminary characterization of methotrexate (MTX) resistance mechanisms in human colon carcinoma cells DLD-1
1999 Caciagli B.; Carotti S.; Morganti M.; Landini I.; Nobili S.; Mazzei T.; Toffoli G.; Mini E
Preliminary characterization of methotrexate (MTX) resistance mechanisms in human colon carcinoma cells DLD-1
1999 Caciagli B.; Carotti S.; Morganti M.; Landini I.; Nobili S.; Mazzei T.; Toffoli G.; Mini E
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1
2001 Caciagli B, Carotti S, Landini I, Morganti M, Nobili S, Coronnello M, Jansen G, Peters GJ, Toffoli G, Priest DG, Mini E
Multiple mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1.
2001 Mini E.; Caciagli B.; Carotti S.; Landini I.; Morganti M.; Nobili S.; Mazzei T.; Toffoli G.; Jansen G.; Peters G.J.; Priest D.J
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines
2001 Carotti S.; Landini I.; Caciagli B.; Nobili S.; Mazzei T.; Mini E
Multiple mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1
2001 Mini E.; Caciagli B.; Carotti S.; Landini I.; Morganti M.; Nobili S.; Coronnello M.; Toffoli G.; Jansen G.; Peters G.J.; Priest D.G.; Mazzei T
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1
2002 Mini E, Caciagli B, Carotti S, Landini I, Morganti M, Nobili S, Coronnello M, Toffoli G, Jansen G, Peters GJ, Priest DG, Mazzei T
Sequence-dependent interactions between oxaliplatin (OHP) and 5-fluorouracil (5-FU) in human colon carcinoma cell lines
2002 Mazzei T.; Carotti S.; Landini I.; Caciagli B.; Nobili S.; Mini E
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines
2003 Landini I; Carotti S; Caciagli B; Morganti M; Napoli C; Nobili S; Giglioni B; Boddi V; Mazzei T; Mini E
Thymidylate Synthase (TS) mRNA expression and TS gene promoter polymorphism in primary colorectal cancer (CRC) patients (PTS) receiving post-operative fluorouracil (5-FU)-based chemotherapy (CT)
2003 Morganti M; Ciantelli M; Giglioni B; Nobili S.; Papi L.; Landini I.; Napoli C.; Valanzano R.; Cianchi F; Boddi V.; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients
2004 Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E.
Molecular characterization of established human colorectal carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil (5-FU) by different selective schedules
2004 A. Tempestini; E. Witort; L. Papucci; N. Schiavone; M. Donnini; A. Lapucci; F. Perna; M. Morganti; B. Caciagli; I. Landini; A. Sobrero; E. Mini; S. Capaccioli
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphysms in primary colorectal cancer patients.
2004 Morganti M, Ciantelli M, Giglioni B, Putignano AL, Nobili S, Papi L, Landini I, Napoli C, Valanzano R, Cianchi F, Boddi V, Tonelli F, Cortesini C, Mazzei T, Genuardi M, Mini E
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I.
2005 R. Ottanà; S. Carotti; R. Maccari; I. Landini; G. Chiricosta; B. Caciagli; MG Vigorita; E. Mini
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers
2005 Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E
Cellular pharmacology of gemcitabine.
2006 E. Mini; S. Nobili; B. Caciagli; I. Landini; T. Mazzei
Pharmacological strategies for overcoming multidrug resistance.
2006 S. Nobili; I. Landini; B. Giglioni; E. Mini
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles
2008 Landini I, Napoli C, Nobili S, Morganti M, Rigacci L, Bosi A, Mini E
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer
2008 Napoli C, Nobili S, Morganti M, Landini I, Cianchi F, Valanzano R, Tonelli F, Mazzei T, Mini E
Comparative genomic hybridization study of genetic changes associated with 5-fluorouracil resistance in HCT-8 colon cancer cell lines: correlations with the expression profiles
2008 Luceri C, Castagnini C, Bigagli E, Toti S, Landini I, Napoli C, Nobili S, Mini E, Dolara P
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Preliminary characterization of methotrexate (MTX) resistance mechanisms in human colon carcinoma cells DLD-1 | 1999 | Caciagli B.; Carotti S.; Morganti M.; Landini I.; Nobili S.; Mazzei T.; Toffoli G.; Mini E | |
Preliminary characterization of methotrexate (MTX) resistance mechanisms in human colon carcinoma cells DLD-1 | 1999 | Caciagli B.; Carotti S.; Morganti M.; Landini I.; Nobili S.; Mazzei T.; Toffoli G.; Mini E | |
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 | 2001 | Caciagli B, Carotti S, Landini I, Morganti M, Nobili S, Coronnello M, Jansen G, Peters GJ, Toffoli G, Priest DG, Mini E | |
Multiple mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1. | 2001 | Mini E.; Caciagli B.; Carotti S.; Landini I.; Morganti M.; Nobili S.; Mazzei T.; Toffoli G.; Jansen G.; Peters G.J.; Priest D.J | |
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines | 2001 | Carotti S.; Landini I.; Caciagli B.; Nobili S.; Mazzei T.; Mini E | |
Multiple mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 | 2001 | Mini E.; Caciagli B.; Carotti S.; Landini I.; Morganti M.; Nobili S.; Coronnello M.; Toffoli G.; Jansen G.; Peters G.J.; Priest D.G.; Mazzei T | |
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 | 2002 | Mini E, Caciagli B, Carotti S, Landini I, Morganti M, Nobili S, Coronnello M, Toffoli G, Jansen G, Peters GJ, Priest DG, Mazzei T | |
Sequence-dependent interactions between oxaliplatin (OHP) and 5-fluorouracil (5-FU) in human colon carcinoma cell lines | 2002 | Mazzei T.; Carotti S.; Landini I.; Caciagli B.; Nobili S.; Mini E | |
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines | 2003 | Landini I; Carotti S; Caciagli B; Morganti M; Napoli C; Nobili S; Giglioni B; Boddi V; Mazzei T; Mini E | |
Thymidylate Synthase (TS) mRNA expression and TS gene promoter polymorphism in primary colorectal cancer (CRC) patients (PTS) receiving post-operative fluorouracil (5-FU)-based chemotherapy (CT) | 2003 | Morganti M; Ciantelli M; Giglioni B; Nobili S.; Papi L.; Landini I.; Napoli C.; Valanzano R.; Cianchi F; Boddi V.; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E | |
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients | 2004 | Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E. | |
Molecular characterization of established human colorectal carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil (5-FU) by different selective schedules | 2004 | A. Tempestini; E. Witort; L. Papucci; N. Schiavone; M. Donnini; A. Lapucci; F. Perna; M. Morganti; B. Caciagli; I. Landini; A. Sobrero; E. Mini; S. Capaccioli | |
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphysms in primary colorectal cancer patients. | 2004 | Morganti M, Ciantelli M, Giglioni B, Putignano AL, Nobili S, Papi L, Landini I, Napoli C, Valanzano R, Cianchi F, Boddi V, Tonelli F, Cortesini C, Mazzei T, Genuardi M, Mini E | |
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I. | 2005 | R. Ottanà; S. Carotti; R. Maccari; I. Landini; G. Chiricosta; B. Caciagli; MG Vigorita; E. Mini | |
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers | 2005 | Morganti M; Ciantelli M; Giglioni B; Putignano AL; Nobili S; Papi L; Landini I; Napoli C; Valanzano R; Cianchi F; Boddi V; Tonelli F; Cortesini C; Mazzei T; Genuardi M; Mini E | |
Cellular pharmacology of gemcitabine. | 2006 | E. Mini; S. Nobili; B. Caciagli; I. Landini; T. Mazzei | |
Pharmacological strategies for overcoming multidrug resistance. | 2006 | S. Nobili; I. Landini; B. Giglioni; E. Mini | |
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles | 2008 | Landini I, Napoli C, Nobili S, Morganti M, Rigacci L, Bosi A, Mini E | |
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer | 2008 | Napoli C, Nobili S, Morganti M, Landini I, Cianchi F, Valanzano R, Tonelli F, Mazzei T, Mini E | |
Comparative genomic hybridization study of genetic changes associated with 5-fluorouracil resistance in HCT-8 colon cancer cell lines: correlations with the expression profiles | 2008 | Luceri C, Castagnini C, Bigagli E, Toti S, Landini I, Napoli C, Nobili S, Mini E, Dolara P |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile